Mechanisms of chronic pain

American Journal of Medicine

Volumn 101, Issue 1 A, 1996, Pages S6-S18

  Markenson, Joseph A ^a,b,c  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b Memorial Hospital   (United States)

^c HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; BRADYKININ; CYTOKINE; HISTAMINE; NITRIC OXIDE; OPIATE DERIVATIVE; OPIATE RECEPTOR; PROSTAGLANDIN DERIVATIVE; SEROTONIN; SUBSTANCE P;

CHRONIC PAIN; HUMAN; NOCICEPTION; PAIN RECEPTOR; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; REVIEW; SECOND MESSENGER; SIGNAL TRANSDUCTION; SPINAL CORD DORSAL HORN;

EID: 0029775784     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9343(96)90030-3     Document Type: Review

References (141)

1. Bonica JJ. Definition and taxonomy of pain. In: Bonica JJ, ed. The Management of Pain, 2nd ed. Philadelphia, PA: Lea & Febiger, 1990:18-27.
2. Bonica JJ. General consideration of chronic pain. In: Bonica JJ, ed. The Management of Pain. 2nd ed. Philadelphia, PA: Lea & Febiger, 1990:189-196.
3. Stacey MJ. Free nerve endings in skeletal muscle of the cat. J Anat. 1969;105:231-254.
4. Chapman CR. Psychological aspects of postoperative pain control. Acta Anaesthesiol Belg. 1992;43:41-52.
5. Fitzgerald M, Lynn B. The sensitization of high threshold mechanoreceptors with myelinated axons by repeated heating. J Physiol. 1977;265:549-563.
6. Bessou P, Perl E. Response of cutaneous sensory units with unmyelinated fibers to noxious stimuli. J Neurophysiol. 1969;32:1025-1043.
7. Fessler RG. Physiology, anatomy, and pharmacology of pain perception. In: Camic PM, Brown FD, eds. Assessing Chronic Pain. A Multi Disciplinary Clinic Handbook. New York: Springer-Verlag, 1989:5-19.
8. Fields HL, Martin JB. Pain: pathophysiology and management. In: Isselbacher K, Brunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL, eds. Harrisons Principles of Internal Medicine, 13th ed. New York: McGraw Hill, 1994:49-55.
9. Meyer RA, Campbell JN, Raja NJ. Peripheral neurologic mechanisms of nociception. In: Wall PD, Melzack R, eds. Textbook of Pain. London: Churchill Livingstone, 1984:13-44.
10. Perl ER. Afferent basis of nociception and pain, evidence from the characteristics of sensory receptors and their projection to the spinal dorsal horn. In: Bonica JJ, ed. Pain. New York: Raven Press, 1980:19-46.
11. Beck PW, Handwerker HO, Zimmermann M. Nervous outflow from the cat's footpad during noxious radiant heat stimulation. Brain Res. 1974;67:373-386.
12. Dubner R. Neurophysiology of pain. Dent Clin North Am. 1978;22:11-30.
13. Dubner R, Ruda MA. Activity-dependent neuronal plasticity following tissue injury and inflammation. Trends Neurosci. 1992;15:96-103.
14. Levine JD, Fields HL, Basbaun A. Peptides and the primary afferent nociceptor. J Neurosci. 1993;13:2273-2286.
15. Konttinen YT, Kemppinen P, Sergerberg M, et al. Peripheral and spinal neural mechanisms in arthritis, with particular reference to treatment of inflammation and pain. Arthritis Rheum. 1994;37:965-982.
16. Whalley ET, Clegg S, Steward JM, Vavrek RJ. Antagonism of the analgesic action of bradykinin on the human blister base. Adv Exp Med Biol. 1989;274A:261-268.
17. Khan AA, Raja SN, Campbell JN, Martke TV, Meyer RA. Bradykinin sensitizes nociceptors to heat stimuli. (Abstr.) Soc Neurosci Abstr. 1986;12:219.
18. Levine J, Taiwo Y. Inflammatory pain. In: Wall PD, Melzack R, eds. Textbook of Pain, 3rd ed. New York: Churchill Livingstone, 1994:45-56.
19. Taiwo YO, Heller PH, Levine JD. Characterization of distinct phospholipases mediating bradykinin and noradrenaline hyperalgesia. Neuroscience. 1990;39:523-531.
20. Farmer SG, Burch RM. Biochemical and molecular pharmacology of kinin receptors. Ann Rev Pharmacol. 1992;32:511-536.
21. Teranka LR, Manning DC, Dehaas JR, et al. Bradykinin as a pain mediator: receptors are localized to sensory neurons and antagonists have analgesic actions. Proc Natl Acad Sci USA. 1988;85:3245-3249.
22. Steen KH, Reech PW, Anton F, Handwerker HO. Protons selectively induce long lasting excitation and sensitization to mechanical stimulation of nociceptors to rat skin, in vitro. J Neurosci. 1992;12:86-95.
23. Richardson BP, Engle G, Donatsch P, Stadler PA. Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs. Nature. 1985;316:126-131.
24. 3 receptors mediate two distinct depolarizing responses in rat dorsal root ganglion neurons. Brain Res. 1990;511:71-79.
25. Taiwo YO, Levine JD. Serotonin is a directly acting hyperalgesic agent in the rat. Neuroscience. 1992;48:485-490.
26. Simone DA, Alrejo M, LaMotte RH. Psychophysical studies of the itch sensation and itchy skin ("allokinesis") produced by intracutaneous injection of histamine. Somatosens Mot Res. 1991;8:271-279.
27. Falus A, Meretey K. Histamine and early messenger in inflammatory and immune reactions, Immunol Today. 1992;13:154-156.
28. Chahl LA, Iggo A. The effects of bradykinin and prostaglandin E1 on rat cutaneous nerve activity. Br J Pharmacol. 1977;59:343-347.
29. 2-induced activation and sensitization of articular mechanoreceptors. Neurosci Lett. 1991;124:5-8.
30. Taiwo YO, Levine JD. Further confirmation of the role of adenyl cyclase and of cAMP-dependent protein kinase in primary afferent hyperalgesia. Neuroscience. 1991:44:131-135.
31. Dayer JM, deRochenouteix B, Burrus B, et al. Human recombinant interleukin-1 stimulates collagenase and prostaglandin E-2 production by human synovial cells. J Clin Invest. 1986;77:645-648.
32. Cunha FQ, Lorenzetti BB, Poole S, et al. Interleukin-8 as a mediator of sympathetic pain. Br J Pharmacol. 1991;104:765-767.
33. Cunha FQ, Poole S, Lorenzetti BB, Ferreira SH. The pivotal role of tumor necrosis factor alpha in the development of inflammatory hyperalgesia. Br J Pharmacol. 1992;107:660-664.
34. Lindsay RM, Harmar AJ. Nerve growth factor regulates expression of neuropeptide genes in adult sensory neurons. Nature. 1989;337:362-364.
35. Otten U. Nerve growth factor: a signalling protein between the nervous and the immune systems. In: Basbaum AI, Besson JM, eds. Towards a New Pharmacology of Pain. New York: John Wiley & Sons, 1991:353-363.
36. Lewin GR, Ritter AM, Menddell LM. Nerve growth factor-induced hyperalgesia in the neonatal and adult rat. J Neurosci. 1993;13:2136-2148.
37. Aloe L, Tuveri MA, Carcassi U, et al. Nerve growth factor in the synovial fluid of patients with chronic arthritis. Arthritis Rheum. 1992;35:351-355.
38. Bischoff SC, Dahinded CA. Effect of nerve growth factor on the release of inflammatory mediators by mature human basophils. Blood. 1992;79:2662-2669.
39. Bleehen T, Keele CA. Observations on the algogenic actions of adenosine compounds on the human blister base preparation. Pain. 1977;3:367-377.
40. Taiwo YO, Levine JD. Direct cutaneous hyperalgesia induced by adenosine. Neuroscience. 1990;38:757-762.
41. Harmar A, Keen P. Synthesis and central and peripheral axonal transport of Substance P in a dorsal root ganglion-nerve preparation in vitro. Brain Res. 1982;231:379-385.
42. White DH, Helme RD. Release of substance P from peripheral nerve terminals following electrical stimulation of the sciatic nerve. Brain Res. 1985;336:27-31.
43. Saria A. Substance P in sensory nerve fibers contributes to the development of oedema in the rat hindpaw after thermal injury. Br J Pharmacol. 1984;323:341-342.
44. Lotz M, Carson DA, Vaughan JH. Substance P activation of rheumatoid synoviocytes: neural pathway in the pathogenesis of arthritis. Science. 1987;235:885-893.
45. Johnson A, Endros GG. Release of histamine from mast cells by vasoactive peptides. Proc Soc Exp Biol Med. 1973;142:1252-1256.
46. Moncadq S, Palmer RM, Higgs EA. Nitric oxide physiology, pathophysiology and pharmacology. Pharmacol Rev. 1991;43:109-142.
47. Haley JE, Dickenson AH, Schachter M. Electrophysiolog cal evidence for a role of nitric oxide in prolonged chemical nociception in the rat. Neuropharmacology. 1992;31:251-258.
48. Levine JD, Lam D, Taiwo YO, Donatoni P, Goetzl EJ. Hyperalgesic properties of 15-lipoxygenase products of arachidonic acid. Proc Nat Acad Sci USA. 1986;83:5331-5334.
49. 4 produces hyperalgesia that is dependent on polymorphonuclear leukocytes. Science. 1984;225:743-745.
50. Levine JD, Gooding J, Donatoni P. The role of the polymorphonuclear leukocyte in hyperalgesia. J Neurosci. 1985;5:3025-3029.
51. Collier HOJ, Roy AO. Morphine like drugs inhibit the stimulation by E prostaglandins of cyclic AMP formation by rat brain homogenate. Nature. 1974;248:24-25.
52. Taiwo YO, Levine JD. Prostaglandin effects after elimination of indirect hyperalgesic mechanisms in the skin of the rat. Brain Res. 1989;492:397-399.
53. Taiwo YO, Levine JD. Contribution of guanine nucleotide regulatory proteins to prostaglandin hyperalgesia in the rat. Brain Res. 1989;492:397-399.
54. Taiwo YO, Levine JD. Kappa and delta opioids block sympathetically dependent hyperalgesia. J Neurosci. 1991;11:928-932.
55. Price DD, Dubner R. Mechanism of first and second pain in the peripheral and central nervous system. J Invest Derm. 1977;69:167-171.
56. Svensson TH. Peripheral, autonomic regulation of locus ceruleus noradrenergic neurons in brain: putative implications for psychiatry and psychopharmacology. Psychopharmacology. 1987;92:1-7.
57. Butler PD, Weiss JM, Stout JC, Nemeroff CB. Corticotropin-releasing factor produces fear-enhancing and behavioral activating effects following infusion into the locus ceruleus. J Neurosci. 1990;10:176-183.
58. Melzack R, Wall PD, Ty TC. Acute pain in the emergency clinic. Pain. 1982;14:33-43.
59. Melzack R, Wall PD. Pain mechanisms: a new theory. Science. 1965;150:971-979.
60. Wall PD. The laminar organization of dorsal horn and effects of descending impulses. J Physiol. 1967;188:403-423.
61. Reynolds DV. Surgery in the rat during electrical analgesia induced by focal brain stimulation. Science. 1969;164:444-445.
62. Mayer DJ, Wolfle TL, Akil H, et al. Analgesia from electrical stimulation in the brainstem of the rat. Science. 1971;174:1351-1354.
63. Mayer DJ, Price DD. Central nervous system mechanisms of analgesia. Pain. 1976;2:379-404.
64. Bonica JJ. Biochemistry and modulation of nociception and pain. In: Bonica JJ, ed. The Management of Pain, 2nd ed. Philadelphia, PA: Lea & Febiger, 1990:95-121.
65. Sagen J, Proudfit HK. Release of endogenous monoamines into spinal cord superfusates following the microinjection of phentolamine into the nucleus raphe magnus. Brain Res. 1987;406:246-254.
66. Basbaum A, Fields HL. Endogenous pain control systems: brain-stem spinal pathways and endorphin circuitry. Annu Rev Neurosci. 1984;7:309-338.
67. Fields HL, Heinricher MM, Mason P. Neurotransmitters in nociceptive modulatory circuits. Annu Rev Neurosci. 1991;14:219-245.
68. Hughes J, Smith TW, Kosterlitz HW, et al. Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature. 1975;258:577-579.
69. Miller RJ. Peptides as neurotransmitters: focus on the enkephalins and endorphins. Pharm Ther. 1981;12:73-108.
70. Watkins LR, Mayer DJ. Organization of endogenous opiate and nonopiate pain control systems. Science. 1982;216:1185-1192.
71. Fields HL. Sources of variability in the sensation of pain. Pain. 1988;33:195-200.
72. Black IB. Molecules and modularity of brain function. In: Information in the Brain: A Molecular Perspective. Cambridge, MA: MIT Press, 1991:101-116.
73. Martin WR, Eades CG, Thompson JA, et al. The effects of morphine and nalorphine-like drugs in the nondependent and morphine-dependent cyclazocine-dependent spinal dog. J Pharm Exp Ther. 1976;197:517-532.
74. Wood PL, Richard JW, Thakur M. Mu opiate iso receptors: differentiation with Kappa agonists. Life Sci. 1982;31:2313-2317.
75. Yaksh TL, Huang SP, Rudy TA. The direct and specific opiate-like effect of met 5-enkephalin and analogs on the spinal cord. Neuroscience. 1977;2:593-596.
76. Freye E. The various effects caused by opioids. In: Freye E, ed. Opioid Agonists, Antagonists and Mixed Narcotic Analgesics: Theoretical Background and Considerations for Practical Use. Berlin, Germany: Springer-Verlag, 1987:27-53.
77. Kitahata LM, Collins JG, Robinson CJ. Narcotic effects on the nervous system. In: Kitahata LM, Collins JG, eds. Narcotic Analgesics in Anesthesiology. Baltimore, MD: Williams & Wilkins, 1982:57-65.
78. Bederson JB, Fields HL, Barbaro NM. Hyperalgesia during naloxone-precipitated withdrawal from morphine is associated with increased on-cell activity in the rostral ventromedial medulla. Somatosens Mot Res. 1990;7:185-203.
79. Mueller RA, Lundberg DB, Breese GR, et al. The neuropharmacy of respiratory control. Pharmacol Rev. 1982;34:255-285.
80. Burks TF. Gastrointestinal pharmacology. Annu Rev Pharmacol Toxicol. 1976;16:15-31.
81. Laubie M, Schmitt H, Vincent M. Vagal bradycardia produced by microinjections of morphine-like drugs into the nucleus ambiguous in anesthetized dogs. Eur J Pharmacol. 1979;59:287-291.
82. Barash P, Kopriva C, Giles R. Global ventricular function and intubation: radionuclear profiles. (Abstr.) Anesthesiology. 1980;53:A109.
83. Lowenstein E, Whitine RB, Bittar DA, et al. Local and neurally mediated effects of morphine on skeletal muscle vascular resistance. J Pharm Exp Ther. 1972;180:359-367.
84. Flacke JW, Flack WE, Boor BC, et al. Histamine release by four narcotics: a double blind study in humans. Anesth Analg. 1987;66:723-730.
85. Hagbarth KE, Kerr DIB. Central influences on spinal afferent conduction. J Neurophysiol. 1954;17:295-307.
86. Carpenter D, Engberg I, Lundberg A. Differential supraspinal control of inhibitory and excitatory actions from the FRA to ascending spinal pathways. Acta Physiol Scand. 1965;63:103-110.
87. Mayer DJ, Liebeskind JC. Pain reduction by focal electrical stimulation of the brain: an anatomical and behavioral analysis. Brain Res. 1974;68:73-93.
88. Boivie J, Meyerson AB. A correlative anatomical and clinical study of pain suppression by deep brain stimulation. Pain. 1982;13:113-126.
89. Baskin DS, Mehler WR, Hosobuchi Y, et al. Autopsy analysis of the safety, efficacy, and cartography of electrical stimulation of the central gray in humans. Brain Res. 1986;371:231-236.
90. Guilbaud G, Besson JM, Oliveras JL, et al. Suppression by LSD of the inhibitory effect exerted by dorsal raphe stimulation on certain spinal cord interneurons in the cat. Brain Res. 1973;61:417-422.
91. Basbaum AI, Clanton CH, Fields HL. Opiate and stimulus-produced analgesia: functional anatomy of a medullospinal pathway. Proc Nat Acad Sci USA. 1976;73:4685-4688.
92. Basbaum AI, Fields HL. Endogenous pain control mechanisms review and hypothesis. Ann Neurol. 1978;4:451-462.
93. Hardy SGP, Leichnetz GR. Cortical projects to the periaqueductal grey in the monkey: a retrograde and orthograde horseradish peroxidase study. Neurosci Lett. 1981;22:97-101.
94. Gray TS, Magnuson DJ. Peptide immunoreactive neurons in the amygdala and the bed nucleus of the stria terminalis project to the midbrain central gray in the rat. Peptides. 1992;13:451-460.
95. Reichling DB, Basbaum AI. Contribution of brainstem GABAergic circuitry to descending antinociceptive controls. I. GABA-immunoreactive projection neurons in the periaqueductal gray and nucleus raphe magnus. J Compar Neurol. 1990;302:370-377.
96. Coffield JA, Bowen KK, Miletic V. Retrograde tracing of projections between the nucleus submedius, the ventrolateral orbital cortex, and the midbrain in the rat. J Comp Neurol. 1992;321:488-499.
97. Herbert H, Saper CR. Organization of medullary adrenergic and nonadrenergic projections to the periaqueductal gray matter in the rat. J Comp Neurol. 1992;314:34-52.
98. Bitz AJ. The sites of origin of brain stem neurotensin and serotonin projections to the rodent nucleus raphe magnus. J Neurosci. 1982;2:819-824.
99. Yaksh TL. Direct evidence that spinal serotonin and noradrenaline terminals mediate the spinal antinociceptive effects of morphine in the periaqueductal gray. Brain Res. 1979;160:180-185.
100. Yeomans DC, Clark FM, Paice JA, et al. Antinociception induced by electrical stimulation of spinally projecting noradrenergic neurons in the A7 catecholamine cell group of the rat. Pain. 1992;48:449-461.
101. Crisp T, Stafinsky JL, Spanos LJ, et al. Analgesic effects of serotonin and receptor-selective serotonin agonists in the rat spinal cord. Gen Pharmacol. 1991;22:247-251.
102. Clark FM, Yeomans DC, Proudfit HK. The noradrenergic innervation of the spinal cord: differences between two substrains of Sprague-Dawley rats determined using retrograde tracers combined with immunochemistry. Neurosci Lett. 1991;125:155-158.
103. Cheng Z-F, Fields HL, Heinricher MM. Morphine microinjected into the periaqueductal gray has differential effects on 3 classes of medullary neurons. Brain Res. 1986;375:57-65.
104. Clark FM, Proudfit HK. Projections of neurons in the ventromedial medulla to pontine catecholamine cell groups involved in the modulation of nociception. Brain Res. 1991;540:105-115.
105. Clark FM, Proudfit HK. The projection of noradrenergic neurons in the A7 catecholamine cell group to the spinal cord in the rat demonstrated by anterograde tracing combined with immunochemistry. Brain Res. 1991;547:279-288.
106. Carstens E, Klumpp D, Zimmerman M. Differential inhibitory effects of medial and lateral midbrain stimulation on spinal neuronal discharges to noxious skin heating in the cat. J Neurophysiol. 1980;43:332-342.
107. Young RF, Tronnier V, Rinaldi PC. Chronic stimulation of the Kölliker-Fuse nucleus region for relief of intractable pain in humans. J Neurosurg. 1992;76:979-985.
108. Gerber G, Randic M. Excitatory amino acids-mediated components of synaptically evoked input from dorsal roots to deep dorsal horn neurons in the rat spinal cord slice. Neurosci Lett. 1989;106:211-219.
109. Gerber G, Randic M. Participation of excitatory amino acid receptors in the slow synaptic transmission in the rat spinal dorsal horn in vitro. Neurosci Lett. 1989;106:220-228.
110. Thompson SWN, King AE, Woolf CJ. Activity-dependent changes in rat ventral horn neurons in vitro; summation of prolonged afferent evoked postsynaptic depolarizations produce a D-2-amino-5-phosphonovaleric acid sensitive windup. Eur J Neurosci. 1990;2:638-649.
111. Morgan JI, Curran T. Stimulus-transcription coupling in neurons: role of cellular immediate-early genes. Trends Neurosci. 1989;12:459-462.
112. Gogas KR, Presley RW, Levine JD, et al. The antinociceptive action of supraspinal opioids results from an increase in descending inhibitory control: correlation of nociceptive behavior and c-fos expression. Neuroscience. 1991;42:617-628.
113. Jones SL, Light AR. Electrical stimulation in the medullary nucleus raphe magnus inhibits noxious heat-evoked fos protein-like immunoreactivity in the rat lumbar spinal cord. Brain Res. 1990;530:335-338.
114. Basbaum AI, Chi S-I, Levine JD. Peripheral and central contribution to persistent expression of the c-fos proto-oncogene in spinal cord after peripheral nerve injury. In: Willis WD, ed. Hyperalgesia and Allodynia. New York: Raven Press, 1992:295-304.
115. Woolf CJ, Thompson SWM. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation: implications for the treatment of post-injury pain hypersensitivity states. Pain. 1991;44:293-299.
116. Chapman V, Dickenson AH. The combination of NMDA antagonism and morphine produces profound antinociception in the rat dorsal horn. Brain Res. 1992;573:321-323.
117. Yamamoto T, Yaksh TL. Studies on the spinal interaction of morphine and the NMDA antagonist Mk-801 on the hyperalgesia observed in a rat model of sciatic mononeuropathy. Neurosci Lett. 1992;135:67-70.
118. Malmberg AB, Yaksh TL. Hyperalgesia mediated by spinal glutamate or substance P receptor blocked by spinal cyclooxygenase inhibition. Science. 1992;257:1276-1279.
119. Woolf CJ, Wall PD. The relative effectiveness of C-primary afferents of different origins in evoking a prolonged facilitation on the flexor reflex in the rat. J Neurosci. 1986;6:1433-1442.
120. Blumberg H, Janig W. Changes in reflexes of vasoconstrictor neurons supplying the cat hindlimb following chronic nerve lesions. A model for studying mechanisms of reflex sympathetic dystrophy? J Auton Nerv Syst. 1983;7:399-411.
121. Nordin M, Nystrom B, Wallin U, et al. Ectopic sensory discharges and paresthesiae in patients with disorders of peripheral nerves, dorsal roots, and dorsal columns. Pain. 1984;20:231-245.
122. Howe JF, Loeser JD, Calvin WH. Mechanosensitivity of dorsal root ganglia and chronically injured axons. A physiological basis for the radicular pain of nerve root compression. Pain. 1977;3:25-41.
123. Melzack R. Phantom limb pain: implications for treatment of pathological pain. Anesthesiology. 1971;35:409-419.
124. Melzack R, Loeser JD. Phantom body pain in paraplegics: evidence for a central "pattern generating mechanism" for pain. Pain. 1978;4:195-210.
125. Bond MR. The relation of pain to the Eyseneck Personality Inventory, Cornell Medical Index and Whitely Index of Hypochondriasis. Br J Psychiatry. 1971;119:671-678.
126. Sternbach RA, Timmermans G. Personality changes associated with reduction of pain. Pain. 1975;1:177-181.
127. Sternbach RA. Chronic pain as a disease entity. Triangle. 1981;20:27-32.
128. Sternbach RA. Pain patients: traits and treatment. In: Sternbach RA, ed. Psychological Effects of Chronic Pain. New York: Academic Press, 1974:12-19.
129. Terenius LY. Biochemical assessment of chronic pain. In: Kosterlitz HS, Terenius LY, eds. Pain and Society. Basel, Germany: Verlag Chemie, 1980:355-364.
130. Pennebaker JW. The psychology of physical symptoms. In: Pennebaker JW, ed. Personality and Developmental Correlates. New York: Springer-Verlag, 1982:133-151.
131. Perl E. Causalgia: sympathetically aggravated chronic pain from damaged nerves. Pain Clin Updates. 1993;1:1-4.
132. Roberts WJ. A hypothesis on the physiological basis for causalgia and related pains. Pain. 1986;24:297-311.
133. Campbell JN, Meyer RA, Raja SN. Is nociceptor activation by alpha-1 adreno-receptors the culprit in sympathetically maintained pain? APS J. 1992;1:3-11.
134. Janig W. Can reflex sympathetic dystrophy be reduced to an alpha-adrenoreceptor disease? APS J. 1992;1:16-22.
135. Sato J, Perl ER. Adrenergic excitation of cutaneous pain receptors induced by peripheral nerve injury. Science. 1991;251:1608-1610.
136. McLachian EM, Janig W, Devor M, et al. Peripheral nerve injury triggers noradrenergic sprouting within dorsal root ganglion. Nature. 1993;363:543-546.
137. Raja SN, Treede RD, Davis KD. Systemic alpha-adrenergic blockade with phentolamine. A diagnostic test for sympathetically maintained pain. Anesthesiology. 1991;74:691-698.
138. Ghostine SY, Comair YG, Turner DM. Phenoxybenzamine in the treatment of causalgia. J Neurosurg. 1984;60:1263-1268.
139. Abram SE, Lightfoot RW. Treatment of long-standing causalgia with prazosin. Reg Anesth. 1981;6:79-81.
140. De Groat WC. Neuropeptides in pelvic afferent pathways. In: Polak JM, ed. Regulatory Peptides. Basel, Switzerland: Birkhhauser Verlag, 1989:334-361.
141. Koltzenburg M, McMahon SB. The enigmatic role of the sympathetic nervous system in chronic pain. Trends Pharmacol Sci. 1991;12:399-402.